Therapyx, Inc.
Publicly observedBuffalo, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Buffalo | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Therapyx, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CHPPVKPN2VE1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant7 Mar 2019Publicly observed
NIH SBIR/STTR award: IL-10NanoCap® for Therapy of Familial Adenomatous Polyposis
USD 959,868.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Feb 2013Publicly observed
NIH SBIR/STTR award: Therapy and Prophylaxis for Genital Tract Infection
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.